Good morning moomooers! Here are things you need to know about today's Singapore:
●Singapore shares were flat on Thursday; STI down 0.03%
●ComfortDelGro to invest S$30m in autonomous vehicles
●Stocks to watch: LHN, AsiaMedic, SingPost, Hatten Land, SMI Vantage
-Moomoo News SG
Market Trend
Singapore shares opened higher on Thursday. The $FTSE Singapore Straits Time Index(.STI.SG)$ decreased 0.03 per cent to 3,441.42 as at...

$Apple(AAPL.US)$ A lot of people in this discussion board talking about regretting selling stocks. One maneuver I frequently make when I feel a stock is doing really well, but perhaps either becoming too large of a percentage for my portofolio -or- I feel the stock might be way over valued, I’ll just sell a portion of the stock I own (maybe 25%, 50%, 75%, etc.). Then, if the stock really takes off (again), I’ll still get a great return and I’ll avoid the fear of missing out. Alternatively, if it dumps, I won’t be losing nearly as much.
Not an uncommon strategy, but just wanted to remind some folks! I did this today with AAPL. I think I maybe sold like 10% of my shares.

German biotech firm Evotec plans to list on the Nasdaq under the symbol "EVO" on November 4th.
The company would look to raise up to $575.5 million in the IPO by offering 22 million American depositary shares (ADSs) at $26.16 each, according to its filing. Each ADS represents one-half of an ordinary share.
According to Reuters, Evotec SE would seek a valuation of about $9.2 billion in its initial public offering in the United States. BofA Securities and Morgan Stanley are the lead underwriters for the offering.
As of October 31st, The company has a market capitalization of $8.2 billion on the Frankfurt Stock Exchange, where its shares are already listed.
Business Overview
Founded in 1993, Hamburg-headquartered Evotec is an industry-leading drug discovery and development partner for the pharmaceutical and biotechnology industry.
It offers a suite of technologies that enable faster and cheaper drug discoveries by pharmaceutical companies.
The company last year received a grant from the Bill & Melinda Gates Foundation to help identify and develop potential monoclonal antibody drugs for the prevention of severe COVID-19.
Evotec's work to date has resulted in 11 disclosed pipeline assets in clinical development, and over 100 pipeline assets in the discovery and preclinical phase.
In the meanwhile, it has developed a broad multi-disciplinary network of collaborations with over 800 partnerships across the pharmaceutical and biotechnology industry and academia.
Evotec generate revenue through three core collaboration routes:
1)“Fee-for-service”: byproviding stand-alone or fully integrated drug discovery and development solutions to partners on a fee-for-service and FTE-rate basis;
2)EVOroyalty: by receiving milestones and royalties on assets;
3)EVOequity: through equity ownership in emerging, highly innovative companies and translational academic institutional projects.
As of June 30, 2021, it had 24 investments with 90 active projects in our EVOequity pipeline.
Financial Performance
Revenues from contracts with customers increased by 17.5%, from €231.0 million for the six months ended June 30, 2020 to €271.3 million in the six months ended June 30, 2021.
The increase is mainly due to a positive performance across all business lines as well as the higher contribution of Just – Evotec Biologics.
Net income increased by €105.5 million from €7.26 million in the six months ended June 30, 2020 to €112.71 million in the six months ended June 30, 2021. The increase is mainly resulted from the fair value adjustment of Evotec’s participation in Exscientia Ltd. in the amount of €116.1 million.
Click to view the prospectus
$Evotec(EVO.US)$

Stocks set for steady open as policy meetings loom
Asian stocks looked set for a steady open Tuesday as traders evaluated a record-high close for U.S. equities and awaited key central bank decisions amid concerns about elevated inflation.
Futures were little changed for Japan and rose for Hong Kong. Australian stocks opened little changed. U.S. contracts fluctuated after optimism over corporate earnings saw the $S&P 500 Index(.SPX.US)$ hit a new peak and the $Dow Jones Industrial Average(.DJI.US)$ touch 36,000 for the first time. Electric-vehicle giant $Tesla(TSLA.US)$ extended a rally. An index of Chinese stocks traded in the U.S. jumped the most since early October.
Smaller stocks are poised to shine, dot-com veteran Jacob says
Ryan Jacob, a veteran of the dot-com boom-and-bust era who has worked his way back to the upper reaches of the fund-performance heap, isn't worried about equities being expensive, though he expects smaller stocks to outperform heading into 2022.
"We're heading for a period where small caps are going to outperform large caps to a significant degree. And it has to do with interest rates" heading higher, he said.
GameStop leads the way as meme stocks eye best day since August
A group of retail-trader favorites is on pace for its best day since late August, led by a mid-afternoon surge for $GameStop(GME.US)$.
The basket of 37 so-called meme stocks tracked by Bloomberg soared as much as 14% Monday as trading volume for the video game retailer and speculative peers accelerated. GameStop and $SoFi Technologies(SOFI.US)$ led the group higher as mentions on platforms like Stocktwits and Reddit's WallStreetBets jumped.
Singapore has grand ambitions to become a global crypto hub
"We think the best approach is not to clamp down or ban these things," said Ravi Menon, managing director of the Monetary Authority of Singapore, which regulates banks and financial firms.
Instead, MAS is putting in place "strong regulation," so firms that meet its requirements and address the multitude of risks can operate, he said in an interview.
Rivian Automotive targets IPO valuation just above $60 billion
$Rivian Automotive(RIVN.US)$ is seeking a valuation in a range just above $60 billion in its initial public offering next week, one of the biggest and most-anticipated deals yet in a blockbuster year for new issues.
Shiba inu passes dogecoin in the top 10 cryptocurrencies
Two meme cryptocurrencies, both inspired by shiba inu dogs, are now within the top 10 by market value.
As of Monday afternoon, dogecoin, which launched in 2013 as a joke, ranks No.10 with a market value of over $35 billion, according to CoinGecko. It’s currently trading at around 27 cents. A token called shiba inu, which launched in 2020 to poke fun at dogecoin, ranks No.9 with a market value of over $38 billion. Shiba inu hit an all-time high of $0.00008616 on Thursday.
Amazon plans to launch its first internet satellites in late 2022
"There is no substitute for on-orbit testing, and we expect to learn a lot given the complexity and risk of operating in such a challenging environment," $Amazon(AMZN.US)$ vice president of technology Rajeev Badyal said in a statement.
Called KuiperSat-1 and KuiperSat-2, Amazon said the satellites will launch with rocket builder ABL Space on its RS1 vehicle.
A Singapore start-up raked in almost $3 million in sales in 2 months — all through Facebook
In September 2020, the three co-founders of Singapore-based Mdada, a social commerce start-up, did their first $Meta Platforms(FB.US)$ livestream to sell products.
To date, Mdada has garnered more than 5 million livestream views, with more than 28,000 followers. The company has grown to almost 30 employees. Mdada's unaudited revenue for the financial year ended Sept. 30 came in at about $15 million Singapore dollars ($11.1 million).
Source: Bloomberg, WSJ, CNBC